Upstart's Biggest Risk Isn't AI—It's Its Funding Model
Upstart gained fame for its AI-driven lending, but the real stakes for investors lie in who funds the loans. This art...
We break down expense ratios across popular index funds and show how choosing the lowest-cost options can improve long-term retirement outcomes.
28,023 articlesUpstart gained fame for its AI-driven lending, but the real stakes for investors lie in who funds the loans. This art...
As the Fed signals potential slower rate moves, tech stocks gyrate. The standout is a cash-generating giant deliverin...
A surge of headlines about aliens and the Catholic Church is reshaping how investors think about religion, charity, a...
When Netflix reportedly missed out on Roku, investors asked: what does this mean for the company’s future profits and...
When a quarterly earnings call drops, investors seek signals that move prices. This practical guide uses the caap 202...
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
A once-sacrosanct pledge to never dump bitcoin treasury holdings is showing cracks as firms explore selling slices to...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
Salesforce unveiled a record $25 billion accelerated share repurchase funded by debt as it posted quarterly results. ...
When prominent athletes face controversy, the financial implications go beyond contracts. This piece explores how Adr...
Berkshire Hathaway is positioned to become a much larger Alphabet holder as the tech giant pursues a bold AI financin...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...